scholarly journals Fermentation characteristics and inhibitory effect of brown rice vinegar on adipocyte differentiation in 3T3-L1 cells

2021 ◽  
Vol 28 (3) ◽  
pp. 416-425
Author(s):  
Eun Ah Sim ◽  
Hyeon Hwa Oh ◽  
Do Youn Jeong ◽  
Geun-Seoup Song ◽  
Young-Soo Kim
2015 ◽  
Vol 5 (9) ◽  
pp. 732-736 ◽  
Author(s):  
Ee-Ling Kong ◽  
Boon-Kiat Lee ◽  
Michelle ◽  
Irine Ginjom ◽  
Peter Morin Nissom

PROTEOMICS ◽  
2008 ◽  
Vol 8 (3) ◽  
pp. 569-581 ◽  
Author(s):  
Md. Atiar Rahman ◽  
Suresh G. Kumar ◽  
Sang Woo Kim ◽  
Hye Jin Hwang ◽  
Yu Mi Baek ◽  
...  

2006 ◽  
Vol 290 (2) ◽  
pp. E273-E281 ◽  
Author(s):  
Hang-Seng Liu ◽  
Yen-Hang Chen ◽  
Pei-Fang Hung ◽  
Yung-Hsi Kao

Resistin (Rstn) is known as an adipocyte-specific secretory hormone that can cause insulin resistance and decrease adipocyte differentiation. By contrast, green tea catechins, especially (−)-epigallocatechin gallate (EGCG), have been reported as body weight and diabetes chemopreventatives. Whether EGCG regulates production of Rstn is unknown. Using 3T3-L1 adipocytes, we found that EGCG at 20 and 100 μM suppressed Rstn mRNA levels by ∼35 and 50%, respectively, after 3 h. The basal half-life of Rstn mRNA induced by actinomycin D was >12 h but shifted to 3 h in the presence of EGCG. This suggests that EGCG regulates the stability of Rstn mRNA. Treatment with cycloheximide did not prevent EGCG-suppressed Rstn mRNA levels, which suggests that the effect of EGCG does not require new protein synthesis. Intracellular Rstn protein significantly decreased in the presence of 100 μM EGCG 3 h after treatment, whereas the release of the Rstn protein did not significantly change. This suggests that EGCG may modulate the distribution of Rstn protein between the intracellular and extracellular compartments. EGCG did not affect the amounts of extracellular signal-related kinase-1/2 (ERK1/2), phospho-JNK, phospho-p38, and phospho-Akt proteins but reduced the amounts of phospho-ERK1/2 proteins. Overexpression with MEK1 blocked EGCG-inhibited Rstn mRNA expression. These data suggest that EGCG downregulates Rstn expression via a pathway that is dependent on the ERK pathway.


2020 ◽  
Author(s):  
Zheng Wang ◽  
Qiang-Sen Zhao ◽  
Xiao-Qin Li ◽  
Zhong-Tao Yin ◽  
Si-Rui Chen ◽  
...  

Abstract Background: A considerable number of muscle development-related genes were differentially expressed in the early stage of avian adipocyte differentiation. However, the functions of them in adipocyte differentiation remain largely known. In this study, the myoblast determination protein 1 (MYOD1) was selected as a representative of muscle development and we investigated its expression, function and regulation in avian adipocyte differentiation.Results: The expression of MYOD1 decreased significantly in the early stage of avian adipocyte differentiation. CRISPR/CAS9-mediated deletion of MYOD1 induced adipocyte differentiation, whereas over-expression of MYOD1 inhibited adipogenesis. mRNA-seq showed that MYOD1 could perturb the lipid biosynthetic process during differentiation. Mechanistically, MYOD1 directly up-regulates the miR-206 expression by binding upstream 1200 bp region, and over-expression of miR-206 also inhibits adipogenesis. Furthermore, MYOD1 affected the expression of endogenous miR-206 and its target gene Kruppel Like Factor 4 (KLF4), which is an important activator of adipogenesis. Accordingly, the inhibition of miR-206 or over-expression of KLF4 could counteract the inhibitory effect of MYOD1 on adipocyte differentiation. Conclusions: These findings suggest that MYOD1 inhibited adipocyte differentiation by up-regulating miR-206 to suppress the KLF4 expression. Collectively, these findings identify a novel function of MYOD1 in adipocyte differentiation, suggesting a potential role in body-fat distribution regulation.


2011 ◽  
Vol 18 (6) ◽  
pp. 875-883 ◽  
Author(s):  
Chang-Ho Baek ◽  
Ji-Ho Choi ◽  
Han-Seok Choi ◽  
Seok-Tae Jeong ◽  
Su-Won Lee ◽  
...  

2013 ◽  
Vol 20 (4) ◽  
pp. 564-572 ◽  
Author(s):  
Chang Ho Baek ◽  
Da-Hee Jeong ◽  
Seong Yeol Baek ◽  
Ji-Ho Choi ◽  
Hye-Young Park ◽  
...  

2019 ◽  
Vol 16 (1) ◽  
Author(s):  
Wen Zhang ◽  
Dan Shen ◽  
Yun Li ◽  
Hong Zhong ◽  
Xing Wang ◽  
...  

Abstract Background Obesity is a global epidemic disease that increases the risk of metabolic syndrome. However, therapeutic drugs for obesity are still scarce. In recent years, peptides have been identified as new biological regulators. RIFV (R-I-F-V-P-I-K-G-R-P-A-P), a novel active peptide from our peptide database. Methods We performed oil red O staining and triglyceride measurement to analyze the influence of RIFV on white preadipocytes differentiation. Then the effects of RIFV on cell proliferation, apoptosis and cell cycle were determined by using CCK-8 assay and flow cytometry. The mRNA and protein levels of adipogenesis-related genes were respectively detected by qRT-PCR and western blot. Rescue experiment was conducted to confirm whether RIFV could regulate adipocytes differentiation via targeting C/EBP-β. Finally, the luciferase reporter gene assay was performed to verify the regulation of RIFV on C/EBP-β gene. Results RIFV was revealed to inhibit the differentiation of human white adipocytes without affecting their proliferation. Additionally, RIFV could also suppress the differentiation of mouse primary white preadipocytes isolated from inguinal fat tissues. Furthermore, RIFV may have an inhibitory effect on adipogenesis by inhibiting the regulation of the adipogenic gene C/EBP-β. Conclusions Our results indicated that RIFV may be a novel essential regulator of adipocyte differentiation and represents a therapeutic strategy for obesity and related complications.


Sign in / Sign up

Export Citation Format

Share Document